These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 561580)

  • 1. [Activated coagulation time under heparin therapy in surgical diseases (author's transl)].
    Matsuda M; Tatsuta N; Aoshima M; Nagai T; Daitoh N
    Nihon Geka Hokan; 1977 Mar; 46(2):113-20. PubMed ID: 561580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring heparin therapy (author's transl)].
    Michaud A; Aiach M; Fourcade MC; Bridey F; Leclerc M
    Ann Pharm Fr; 1978; 36(11-12):513-8. PubMed ID: 754629
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)].
    Vogel GE; Kopp KF
    Med Klin; 1976 Jan; 71(3):116-9. PubMed ID: 1250190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of acute acquired defects of coagulation and their therapy (author's transl)].
    Göbel EA
    Anaesthesist; 1976 Sep; 25(9):449-53. PubMed ID: 970600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theoretical basis and practical carrying out of an APTT control test for exact heparin monitoring (author's transl)].
    Vogel GE
    Med Klin; 1977 Feb; 72(6):207-11. PubMed ID: 840137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Most frequent errors in the laboratory control of oral anticoagulation (author's transl)].
    Duckert F
    Ther Umsch; 1977 May; 34(5):350-4. PubMed ID: 867317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coagulation studies and treatment with heparin in a case of hemolytic-uremic-syndrome (author's transl)].
    Ploier R
    Padiatr Padol; 1974; 9(3):276-81. PubMed ID: 4408956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disorders of haemostasis in postoperative septicaemia (author's transl)].
    Frick U; Wiedenhöft I; Petermann J; Worn V
    Zentralbl Chir; 1980; 105(17):1141-7. PubMed ID: 7456837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The whole blood recalcification clotting time. A suggested simple and reliable method for monitoring heparin therapy.
    Fanning JP; Dubeau AM
    J Maine Med Assoc; 1974 Sep; 65(9):211, 3. PubMed ID: 4416580
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of low-dose-heparin and its control (author's transl)].
    Zanoni G
    Schweiz Rundsch Med Prax; 1976 Apr; 65(16):477-80. PubMed ID: 981166
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new method for the control of heparin therapy].
    Hrcková V; Kousalová J
    Vnitr Lek; 1976 Jan; 22(1):49-51. PubMed ID: 1251560
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Med Klin; 1977 Oct; 72(40):1617-23. PubMed ID: 916946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the anticoagulant effect of heparin "in vivo" (author's transl)].
    Lucia JF; Ercoreca L; García Zueco JC; Cinto F; Raichs A
    Sangre (Barc); 1976; 21(1):77-86. PubMed ID: 772843
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical value of a new method of therapeutic control of heparin].
    Pizzuto J; Garcia S; de la Paz Reyna M; Morales MR; Avilés A; Zavala B; Ponce L; Gaos C
    Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of heparin therapy through the examination of blood coagulation at the hand temperature].
    Pejchl S; Krivohlavý A
    Vnitr Lek; 1976 Nov; 22(11):1118-20. PubMed ID: 1007045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of heparin therapy: sensitivity of the various methods].
    Merino J; González-Boullosa R; Benet I; García-Conde J
    Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.